TAM
IBB icon

Tucker Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Tucker Asset Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$15.7K Hold
93
– – ﹤0.01% 494
2025
Q3 		$13.4K Buy
+93
New +$12.7K ﹤0.01% 244

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Tucker Asset Management's IBB Position: Q4 2025 in Review

Tucker Asset Management held its iShares Biotechnology ETF (IBB) position steady in Q4 2025 at 93 shares worth $15.7K. The position accounts for ﹤0.01% of the portfolio, ranked #494.

Tucker Asset Management first reported a position in IBB in Q3 2025 and has held it in 2 quarters since. 955 funds tracked by Wall St. Rank hold IBB as of Q4 2025.

  • Tucker Asset Management held 93 shares of iShares Biotechnology ETF worth $15.7K as of Q4 2025.
  • Tucker Asset Management left its iShares Biotechnology ETF share count unchanged in Q4 2025.
  • iShares Biotechnology ETF made up ﹤0.01% of Tucker Asset Management's portfolio in Q4 2025, its #494 holding.
  • Tucker Asset Management first reported a position in iShares Biotechnology ETF in Q3 2025 and has held it in 2 quarters since.
  • 955 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2025.

Based on Tucker Asset Management's 13F filing for Q4 2025, filed 5 Feb 2026.